Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Cash Flows from Operating Activities:
Net Income	$ 328,060	$ 293,160
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	115,186	114,295
Restructuring charges, net of payments		(2,341)
Goodwill Impairment	36,745
Fair value adjustments to contingent earnout obligations		2,470
Deferred income taxes	8,506	(16,908)
Stock-based compensation expense	23,636	29,287
Net loss on marketable securities	3,241	10,032
Net (gain) on sales of assets and a business	(25,881)	(42,491)
Other	684	112
Changes in assets and liabilities, net of effect from purchases and sales of businesses:
Decrease in receivables	202,742	170,513
(Increase) in inventory	(142,069)	(273,519)
Decrease in prepaid expenses and other current and long-term assets	4,807	506
(Decrease) in accounts payable	(195,093)	(9,884)
(Decrease) in accrued compensation and benefits	(54,747)	(47,442)
(Decrease) in accrued losses	(2,119)	(2,985)
(Decrease) in other accrued liabilities	(40,690)	(68,854)
Cash Provided by Operating Activities	263,008	155,951
Cash Flows from Investing Activities:
Capital expenditures	(179,725)	(152,401)
Acquisition of businesses, net of cash acquired	(47,542)	(116,457)
Purchase of marketable securities	(13,173)	(13,674)
Proceeds from sales of marketable securities	9,596	9,004
Proceeds from sales of assets and a business, net	53,318	51,913
Other	2,127	(55)
Cash (Used for) Investing Activities	(175,399)	(221,670)
Cash Flows from Financing Activities:
Additions to long-term and short-term debt	489,881	300,967
Reductions of long-term and short-term debt	(354,135)	(72,493)
Cash dividends	(159,841)	(152,575)
Repurchases of common stock	(37,500)	(27,500)
Shares of common stock returned for taxes	(15,252)	(10,906)
Payments of acquisition-related contingent consideration	(3,765)	(5,774)
Other	(2,689)	(3,824)
Cash (Used for) Provided by Financing Activities	(83,301)	27,895
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(12,110)	(15,689)
Net Change in Cash and Cash Equivalents	(7,802)	(53,513)
Cash and Cash Equivalents at Beginning of Period	201,672	246,704
Cash and Cash Equivalents at End of Period	193,870	193,191
Cash paid during the period for:
Interest	83,248	58,129
Income Taxes, net of refunds	133,753	130,862
Supplemental Disclosures of Noncash Investing Activities:
Capital expenditures accrued within accounts payable at quarter-end	$ 12,147	$ 9,390